Related Experiment Videos
[Synopsis: gastrointestinal lymphomas]
Agnès Ruskoné-Fourmestraux1, Anne Lavergne-Slove, Alain Delmer
1Service de Gastro-Entérologie, Hôtel Dieu, 1 place du parvis Notre-Dame, 75004 Paris. agnes.fourmestraux@htd.ap-hop-paris.fr
Gastroenterologie Clinique Et Biologique
|May 1, 2002
Summary
No abstract available in PubMed .
Related Concept Videos
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Measurable residual disease-guided combination of ibrutinib plus venetoclax versus FCR in previously untreated patients with intermediate-risk chronic lymphocytic leukaemia: a phase 2, randomised trial (ERADIC) from the FILO group.
EClinicalMedicine·2026
Same author
Autologous and Allogeneic Stem-Cell Transplantation for Transformed Waldenström Macroglobulinemia.
American journal of hematology·2024
Same author
Simplified Risk Stratification Model for Patients With Waldenström Macroglobulinemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2024
Same author
High efficacy of CD19 CAR T cells in patients with transformed Waldenström macroglobulinemia.
Blood·2024
Same author
Clinical Management of Patients with Gastric MALT Lymphoma: A Gastroenterologist's Point of View.
Cancers·2023
Same author
Efficacy and safety of crizotinib in ALK-positive systemic anaplastic large-cell lymphoma in children, adolescents, and adult patients: results of the French AcSé-crizotinib trial.
European journal of cancer (Oxford, England : 1990)·2023